NYSE:HCP - HCP Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HCP, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $37.15 -0.14 (-0.38 %) (As of 02/24/2020 04:00 PM ET) Add Compare Today's Range$37.06Now: $37.15▼$37.6450-Day Range$34.33MA: $36.30▼$37.3352-Week Range$26.58Now: $37.15▼$37.93Volume8.04 million shsAverage Volume2.80 million shsMarket Capitalization$18.24 billionP/E Ratio20.41Dividend Yield4.03%Beta0.22 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustrySpecialized REITs SectorFinance Current SymbolNYSE:HCP Previous Symbol CUSIP40414L10 CIK765880 Webhttp://www.hcpi.com/ Phone949-407-0700Debt Debt-to-Equity Ratio1.01 Current Ratio0.81 Quick Ratio0.81Price-To-Earnings Trailing P/E Ratio20.41 Forward P/E Ratio21.23 P/E Growth6.81 Sales & Book Value Annual Sales$1.85 billion Price / Sales9.88 Cash Flow$3.49 per share Price / Cash Flow10.65 Book Value$13.70 per share Price / Book2.71Profitability EPS (Most Recent Fiscal Year)$1.82 Net Income$1.06 billion Net Margins43.66% Return on Equity12.78% Return on Assets6.24%Miscellaneous Employees201 Outstanding Shares491,110,000Market Cap$18.24 billion Next Earnings DateN/A OptionableOptionable Receive HCP News and Ratings via Email Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter. HCP Rates by TradingView HCP (NYSE:HCP) Frequently Asked Questions What is HCP's stock symbol? HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP." How often does HCP pay dividends? What is the dividend yield for HCP? HCP announced a quarterly dividend on Wednesday, October 23rd. Stockholders of record on Monday, November 4th will be paid a dividend of $0.37 per share on Tuesday, November 19th. This represents a $1.48 annualized dividend and a dividend yield of 3.98%. The ex-dividend date is Friday, November 1st. View HCP's Dividend History. How were HCP's earnings last quarter? HCP, Inc. (NYSE:HCP) announced its quarterly earnings data on Wednesday, October, 30th. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.43 by $0.52. The real estate investment trust earned $538 million during the quarter, compared to analyst estimates of $503.65 million. HCP had a return on equity of 12.78% and a net margin of 43.66%. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.44 earnings per share. View HCP's Earnings History. What price target have analysts set for HCP? 8 Wall Street analysts have issued twelve-month price targets for HCP's shares. Their forecasts range from $35.00 to $39.00. On average, they anticipate HCP's stock price to reach $37.00 in the next year. This suggests that the stock has a possible downside of 0.4%. View Analyst Price Targets for HCP. What is the consensus analysts' recommendation for HCP? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCP. Has HCP been receiving favorable news coverage? Press coverage about HCP stock has trended neutral recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. HCP earned a news sentiment score of 0.4 on InfoTrie's scale. They also assigned media coverage about the real estate investment trust a news buzz of 9.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for HCP. Who are some of HCP's key competitors? Some companies that are related to HCP include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Ventas (VTR), Weyerhaeuser (WY), Extra Space Storage (EXR), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), EPR Properties (EPR), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP) and Sabra Health Care REIT (SBRA). What other stocks do shareholders of HCP own? Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), AbbVie (ABBV), Verizon Communications (VZ), Realty Income (O), Cisco Systems (CSCO), Intel (INTC), Walt Disney (DIS) and Johnson & Johnson (JNJ). Who are HCP's key executives? HCP's management team includes the folowing people: Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)Mr. Peter A. Scott, Exec. VP & CFO (Age 39)Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46) Who are HCP's major shareholders? HCP's stock is owned by a number of of retail and institutional investors. Top institutional investors include Aurora Investment Managers LLC. (0.00%). Company insiders that own HCP stock include Christine Garvey, R Kent Griffin Jr and Thomas Klaritch. View Institutional Ownership Trends for HCP. Which institutional investors are buying HCP stock? HCP stock was bought by a variety of institutional investors in the last quarter, including Aurora Investment Managers LLC.. View Insider Buying and Selling for HCP. How do I buy shares of HCP? Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is HCP's stock price today? One share of HCP stock can currently be purchased for approximately $37.15. How big of a company is HCP? HCP has a market capitalization of $18.24 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 201 workers across the globe.View Additional Information About HCP. What is HCP's official website? The official website for HCP is http://www.hcpi.com/. How can I contact HCP? HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected] MarketBeat Community Rating for HCP (NYSE HCP)Community Ranking: 1.9 out of 5 ()Outperform Votes: 526 (Vote Outperform)Underperform Votes: 861 (Vote Underperform)Total Votes: 1,387MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/24/2020 by MarketBeat.com StaffFeatured Article: What do I need to know about analyst ratings?
